Stay updated on HMPL-523 in Hematologic Malignancies Clinical Trial
Sign up to get notified when there's something new on the HMPL-523 in Hematologic Malignancies Clinical Trial page.

Latest updates to the HMPL-523 in Hematologic Malignancies Clinical Trial page
- CheckyesterdayNo Change Detected
- Check8 days agoChange DetectedThe web page has been updated from version 2.15.0 to version 2.15.2, indicating a revision in the content.SummaryDifference0.1%
- Check16 days agoNo Change Detected
- Check23 days agoChange DetectedThe web page has undergone significant changes, including the removal of detailed study information regarding HMPL-523 for hematologic malignancies, while retaining the study's title and collaborators. A revision number has also been updated.SummaryDifference51%
- Check30 days agoChange DetectedThe web page has been updated from version 2.14.3 to version 2.14.4.SummaryDifference0.1%
- Check74 days agoChange DetectedThe page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products.SummaryDifference1%
- Check88 days agoChange DetectedThe page now includes a notice about heavy traffic affecting the performance and availability of some NLM-NCBI services and products, along with a contact email for assistance.SummaryDifference1%
- Check95 days agoChange DetectedThe website has been updated from version v2.14.1 to v2.14.2.SummaryDifference0.1%
Stay in the know with updates to HMPL-523 in Hematologic Malignancies Clinical Trial
Enter your email address, and we'll notify you when there's something new on the HMPL-523 in Hematologic Malignancies Clinical Trial page.